Cargando…

A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression

Detalles Bibliográficos
Autores principales: Su, Ganglin, Yao, Lin, Han, Xiaohong, Liao, Xinhui, Chen, Jieqing, Yin, Tao, Dong, Ying, Li, Yanfeng, Hu, Kun, Xiao, Junwen, Liu, Yuchen, Huang, Weiren, Mei, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882238/
https://www.ncbi.nlm.nih.gov/pubmed/35220684
http://dx.doi.org/10.1002/ctm2.734
_version_ 1784659649554808832
author Su, Ganglin
Yao, Lin
Han, Xiaohong
Liao, Xinhui
Chen, Jieqing
Yin, Tao
Dong, Ying
Li, Yanfeng
Hu, Kun
Xiao, Junwen
Liu, Yuchen
Huang, Weiren
Mei, Hongbing
author_facet Su, Ganglin
Yao, Lin
Han, Xiaohong
Liao, Xinhui
Chen, Jieqing
Yin, Tao
Dong, Ying
Li, Yanfeng
Hu, Kun
Xiao, Junwen
Liu, Yuchen
Huang, Weiren
Mei, Hongbing
author_sort Su, Ganglin
collection PubMed
description
format Online
Article
Text
id pubmed-8882238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88822382022-03-02 A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression Su, Ganglin Yao, Lin Han, Xiaohong Liao, Xinhui Chen, Jieqing Yin, Tao Dong, Ying Li, Yanfeng Hu, Kun Xiao, Junwen Liu, Yuchen Huang, Weiren Mei, Hongbing Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-02-27 /pmc/articles/PMC8882238/ /pubmed/35220684 http://dx.doi.org/10.1002/ctm2.734 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Su, Ganglin
Yao, Lin
Han, Xiaohong
Liao, Xinhui
Chen, Jieqing
Yin, Tao
Dong, Ying
Li, Yanfeng
Hu, Kun
Xiao, Junwen
Liu, Yuchen
Huang, Weiren
Mei, Hongbing
A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title_full A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title_fullStr A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title_full_unstemmed A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title_short A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
title_sort synthetic targeted rna demethylation system based on crispr‐cas13b inhibits bladder cancer progression
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882238/
https://www.ncbi.nlm.nih.gov/pubmed/35220684
http://dx.doi.org/10.1002/ctm2.734
work_keys_str_mv AT suganglin asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT yaolin asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT hanxiaohong asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liaoxinhui asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT chenjieqing asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT yintao asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT dongying asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liyanfeng asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT hukun asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT xiaojunwen asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liuyuchen asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT huangweiren asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT meihongbing asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT suganglin synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT yaolin synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT hanxiaohong synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liaoxinhui synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT chenjieqing synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT yintao synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT dongying synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liyanfeng synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT hukun synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT xiaojunwen synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT liuyuchen synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT huangweiren synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression
AT meihongbing synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression